skip to main content
Show Results with:

Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

Gastric Cancer, Nov 2017, Vol.20(6), pp.970-977 [Peer Reviewed Journal]

No full-text

Searching Remote Databases, Please Wait